Patients were randomly assigned to receive oral crizotinib at a dose of @ mg twice daily or to receive intravenous chemotherapy ( pemetrexed , @ mg per square meter of body-surface area , plus either cisplatin , @ mg per square meter , or carboplatin , target area under the curve of @ to @ mg per milliliter per minute ) every @ weeks for up to six cycles .